HCA Healthcare, Inc. $HCA Shares Bought by Nomura Asset Management Co. Ltd.

Nomura Asset Management Co. Ltd. lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 2.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 61,124 shares of the company’s stock after buying an additional 1,574 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in HCA Healthcare were worth $23,417,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in HCA. Price T Rowe Associates Inc. MD lifted its stake in shares of HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after purchasing an additional 1,091,416 shares during the period. Goldman Sachs Group Inc. boosted its stake in shares of HCA Healthcare by 49.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock worth $615,583,000 after acquiring an additional 587,036 shares in the last quarter. Nuveen LLC purchased a new position in HCA Healthcare in the 1st quarter valued at approximately $569,217,000. Pacer Advisors Inc. boosted its position in HCA Healthcare by 6,237.9% during the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock worth $466,815,000 after purchasing an additional 1,329,618 shares in the last quarter. Finally, Nordea Investment Management AB increased its position in shares of HCA Healthcare by 6.8% in the second quarter. Nordea Investment Management AB now owns 927,781 shares of the company’s stock valued at $350,404,000 after buying an additional 59,163 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on HCA. TD Cowen upped their price objective on HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a research report on Monday, October 27th. Jefferies Financial Group upped their target price on shares of HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a report on Tuesday, October 28th. Weiss Ratings reissued a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a report on Monday, October 27th. Finally, UBS Group increased their price target on HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a report on Monday, October 27th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and ten have given a Hold rating to the company. According to MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $474.53.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $478.64 on Wednesday. The firm has a market cap of $109.22 billion, a PE ratio of 18.50, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $480.00. The firm’s 50-day simple moving average is $436.04 and its 200-day simple moving average is $398.67.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter in the prior year, the firm posted $4.90 earnings per share. HCA Healthcare’s revenue for the quarter was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio is 11.13%.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.